Major Biotechs See Rising Tide in Short Interest
The March 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
All Work
Chris Lange
Short Sellers Up the Ante on Social Media Stocks
The March 15 short interest data have been compared with the previous report. Short interest in most of these selected social media stocks increased for this settlement date.
Which Major Pharma Stocks Short Sellers Are Keen On
The March 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Cybersecurity Short Sellers Grow More Selective
The March 15 short interest data have been compared with the previous figures, and short interest moves in these selected cybersecurity stocks were mixed.
Monday’s Biggest Winners and Losers in the S&P 500
Monday was an incredible day for the broad U.S. markets, with the Dow posting one of its top 3 performances, in terms of points, in the history of the average. The S&P 500 and…
Who Stands to Benefit the Most From the Toys ‘R’ Us Shutdown
Toys “R” Us generated over $7 billion in sales in the United States in the year ended January 2017, which means that all this cash is up for grabs among major retailers.
Why the National Institute of Health New Budget Looks So Promising
According to a recent analyst report by Janney, the National Institute of Health budget that was approved last Friday could be a big boost for some select biopharma stocks.
Are Finish Line Shareholders Getting Enough in the Buyout?
The Finish Line, Inc. (NASDAQ: FINL) shares made a solid gain early on Monday after the firm announced that it would be acquired by JD Sports Fashion. Overall, this transaction offers a great opportunity…
Paychex Q3 Earnings, Upbeat Outlook Were Not Enough
Paychex, Inc. (NASDAQ: PAYX) released its fiscal third-quarter financial results before the markets opened on Monday. The company said that it had $0.63 in earnings per share (EPS) on $866.5 million in revenue, compared…
Lowe’s Plans Ahead for CEO Departure
Lowe’s Companies shares made a handy gain early on Monday after the firm announced that it would soon be implementing its succession plan.
Spotify Issues Guidance Ahead of IPO
Early on Monday ahead of its expected IPO date of April 3, Spotify released guidance for what the firm expects to see going forward.
BlackBerry, GameStop, Walgreens and More Earnings to Watch For This Week
24/7 Wall St. has put together a preview of Lululemon, Walgreens and some of the other top companies reporting their latest results in the coming week.
How Analysts See AbbVie After the Big Disappointment
AbbVie shares took a big step back last week after the firm reported less than favorable results for its relapsed/refractory small cell lung cancer trial.
Pivotal Software Gears Up for IPO
Leading cloud-native platform provider Pivotal Software has filed with the SEC regarding its initial public offering.
Meet the World’s New Largest Cruise Ship
Summer is just around the corner, and with that comes the busy season for cruise liners. This year it seems that Royal Caribbean Cruises will be boasting the biggest boat of the group, as…
Friday’s Biggest Winners and Losers in the S&P 500
Friday was again an absolute disaster for the broad U.S. markets. There didn’t seem to be anything positive about Friday, with the exception of gold and oil rising. The Nasdaq was the biggest loser…
Dropbox Enters the Market With a Bang (UPDATED)
Dropbox entered the market with a bang on Friday, with shares opening well above their announced pricing.
Why Analysts Are Chasing Nike Even Higher
After Nike reported fiscal third-quarter results on Thursday, analysts have cheered on this report, hiking their price targets.
Why Analysts Are Still Bullish on Micron Technology
Micron Technology released fiscal second-quarter financial results on Thursday, and despite a setback with this report, analysts still seem overly positive on the stock.
Pfizer’s Chantix Study Goes Up in Smoke
Pfizer shares slipped slightly on Friday after the pharma giant announced results from its Chantix/Champix smoking cessation study in adolescents.